204 related articles for article (PubMed ID: 38635628)
1. Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons.
Mohd Rafiq N; Fujise K; Rosenfeld MS; Xu P; De Camilli P
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2318943121. PubMed ID: 38635628
[TBL] [Abstract][Full Text] [Related]
2. Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons.
Rafiq NM; Fujise K; Rosenfeld MS; Xu P; Wu Y; De Camilli P
bioRxiv; 2023 Oct; ():. PubMed ID: 37873399
[TBL] [Abstract][Full Text] [Related]
3. Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons.
Cao M; Wu Y; Ashrafi G; McCartney AJ; Wheeler H; Bushong EA; Boassa D; Ellisman MH; Ryan TA; De Camilli P
Neuron; 2017 Feb; 93(4):882-896.e5. PubMed ID: 28231468
[TBL] [Abstract][Full Text] [Related]
4. Absence of Sac2/INPP5F enhances the phenotype of a Parkinson's disease mutation of synaptojanin 1.
Cao M; Park D; Wu Y; De Camilli P
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12428-12434. PubMed ID: 32424101
[TBL] [Abstract][Full Text] [Related]
5. Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathology.
Ng XY; Wu Y; Lin Y; Yaqoob SM; Greene LE; De Camilli P; Cao M
NPJ Parkinsons Dis; 2023 Feb; 9(1):26. PubMed ID: 36792618
[TBL] [Abstract][Full Text] [Related]
6. The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals.
Vanhauwaert R; Kuenen S; Masius R; Bademosi A; Manetsberger J; Schoovaerts N; Bounti L; Gontcharenko S; Swerts J; Vilain S; Picillo M; Barone P; Munshi ST; de Vrij FM; Kushner SA; Gounko NV; Mandemakers W; Bonifati V; Meunier FA; Soukup SF; Verstreken P
EMBO J; 2017 May; 36(10):1392-1411. PubMed ID: 28331029
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
[TBL] [Abstract][Full Text] [Related]
8. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
9. Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice.
Pan PY; Sheehan P; Wang Q; Zhu X; Zhang Y; Choi I; Li X; Saenz J; Zhu J; Wang J; El Gaamouch F; Zhu L; Cai D; Yue Z
Hum Mol Genet; 2020 Aug; 29(14):2300-2312. PubMed ID: 32356558
[TBL] [Abstract][Full Text] [Related]
10. MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins.
Adayev T; Chen-Hwang MC; Murakami N; Wang R; Hwang YW
Biochem Biophys Res Commun; 2006 Dec; 351(4):1060-5. PubMed ID: 17097615
[TBL] [Abstract][Full Text] [Related]
11. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
[TBL] [Abstract][Full Text] [Related]
12. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
[TBL] [Abstract][Full Text] [Related]
13. Synaptojanin 1 contributes to maintaining the stability of GABAergic transmission in primary cultures of cortical neurons.
Luthi A; Di Paolo G; Cremona O; Daniell L; De Camilli P; McCormick DA
J Neurosci; 2001 Dec; 21(23):9101-11. PubMed ID: 11717343
[TBL] [Abstract][Full Text] [Related]
14. Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease.
Zou L; Zhang X; Xiong M; Meng L; Tian Y; Pan L; Yuan X; Chen G; Wang Z; Bu L; Yao Z; Zhang Z; Ye K; Zhang Z
Neurobiol Dis; 2021 Jul; 154():105326. PubMed ID: 33677035
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of the Human Nigro-striatal Pathway on-a-Chip Reveals OPA1-Dependent Mitochondrial Defects and Loss of Dopaminergic Synapses.
Iannielli A; Ugolini GS; Cordiglieri C; Bido S; Rubio A; Colasante G; Valtorta M; Cabassi T; Rasponi M; Broccoli V
Cell Rep; 2019 Dec; 29(13):4646-4656.e4. PubMed ID: 31875567
[TBL] [Abstract][Full Text] [Related]
16. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
[TBL] [Abstract][Full Text] [Related]
17. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
[TBL] [Abstract][Full Text] [Related]
18. Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons.
Peng SP; Schachner M; Boddeke E; Copray S
Cell Reprogram; 2016 Apr; 18(2):55-66. PubMed ID: 26990843
[TBL] [Abstract][Full Text] [Related]
19. Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages.
Perera RM; Zoncu R; Lucast L; De Camilli P; Toomre D
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19332-7. PubMed ID: 17158794
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease in a dish - Using stem cells as a molecular tool.
Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
